Fortress Biotech Inc. (FBIO) NASDAQ

$2 (0.17) (-7.83%)

Market Cap: $19.41M

As of 03/28/24 04:00 PM EDT. Market closed.

(FBIO)

Fortress Biotech Inc. (FBIO)
NASDAQ

$2
(0.17) (-7.83%)

Market Cap: $19.41M

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

fortress biotech, inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as fortress companies. the company will leverage its biopharmaceutical business ... read more

fortress biotech, inc. is a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products. fortress plans to develop and commercialize products that it acquires both directly as well as indirectly by establishing subsidiary companies, also known as fortress companies. the company will leverage its biopharmaceutical business expertise and drug development capabilities to help the fortress companies achieve their goals. additionally, the company will provide funding and management services to each of the fortress companies and from time to time the company and the fortress companies will seek licensing, partnerships, joint ventures, and/or public and private financings to accelerate and provide additional funding to support their research and development programs. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Lindsay Rosenwald
Full Time Employees
38
CEO Compensation (Base)
$31,497
CEO Compensation (Total)
$2.37M
URL
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Lindsay Rosenwald
Full Time Employees
38
CEO Compensation (Base)
$31,497
CEO Compensation (Total)
$2.37M
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
PRICE CHART FOR FORTRESS BIOTECH INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.10
Previous Close
$2.17
Days Range
$1.93 - $2.17
52 week range
$1.24 - $12.75
Volume
311,851
Avg. Volume (30 days)
355,016
Market Cap
$19.41M
Dividend Yield
-
P/E
-
Shares Outstanding
8,942,751
Open
$2.10
Previous Close
$2.17
Days Range
$1.93 - $2.17
52 week range
$1.24 - $12.75
Volume
311,851
Avg. Volume (30 days)
355,016
Market Cap
$19.41M
Dividend Yield
-
P/E
-
Shares Outstanding
8,942,751
FINANCIAL STATEMENTS FOR FORTRESS BIOTECH INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR FORTRESS BIOTECH INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanJan 05, 2024 Buy$2.3850,000118,7702,863,905Jan 09, 2024, 08:15 AM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanNov 14, 2023 Buy$1.701,567,5152,664,7762,597,440Nov 16, 2023, 05:50 PM
WEISS MICHAEL SSee RemarksNov 14, 2023 Buy$1.70147,058249,9991,130,520Nov 16, 2023, 05:46 PM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanSep 26, 2023 Buy$0.28100,00028,33015,449,091Sep 27, 2023, 08:20 AM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanAug 18, 2023 Buy$9.3410,00093,400112,500Aug 21, 2023, 08:30 AM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanAug 17, 2023 Buy$11.7510,000117,500102,500Aug 21, 2023, 08:30 AM
WEISS MICHAEL SSee RemarksFeb 10, 2023 Buy$0.831,197,604999,99914,752,034Feb 14, 2023, 04:12 PM
Rowinsky Eric KDirectorFeb 10, 2023 Buy$0.8311,97610,000931,976Feb 14, 2023, 04:11 PM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanFeb 10, 2023 Buy$0.832,395,2091,999,99915,349,091Feb 14, 2023, 04:10 PM
Jin DavidChief Financial OfficerFeb 10, 2023 Buy$0.8335,92830,0001,438,757Feb 14, 2023, 04:06 PM
ROSENWALD LINDSAY A MDPresident, CEO & ChairmanJun 01, 2022 Option Exercise$0.734,2643,11311,734,588Jan 04, 2023, 09:28 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANDec 01, 2022 Buy$0.68100,00067,96011,730,324Dec 05, 2022, 07:31 AM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANNov 30, 2022 Buy$0.565,0002,80011,630,324Dec 02, 2022, 04:18 PM
Jin DavidChief Financial OfficerNov 30, 2022 Buy$0.565,0002,8001,402,829Dec 02, 2022, 04:14 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANOct 21, 2022 Buy$0.69100,00069,50011,625,324Oct 24, 2022, 08:00 AM
Klein DovDirectorDec 28, 2021 Sale$2.455,00012,250651,015Apr 29, 2022, 04:26 PM
Hunter RobynChief Financial OfficerSep 21, 2021 Sale$3.1328,29288,554163,877Apr 29, 2022, 04:25 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANDec 01, 2021 Option Exercise$2.421,2503,02510,422,338Apr 29, 2022, 04:22 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANJun 01, 2021 Option Exercise$2.311,2972,99610,408,336Apr 29, 2022, 04:22 PM
Rowinsky Eric KDirectorFeb 05, 2021 Sale$3.804,00015,200746,000Apr 09, 2021, 05:25 PM
Rowinsky Eric KDirectorMar 02, 2021 Sale$4.4510,00044,500720,000Apr 09, 2021, 05:25 PM
Rowinsky Eric KDirectorFeb 19, 2021 Sale$4.318,00034,480730,000Apr 09, 2021, 05:25 PM
Rowinsky Eric KDirectorFeb 18, 2021 Sale$4.206,00025,200738,000Apr 09, 2021, 05:25 PM
Rowinsky Eric KDirectorFeb 16, 2021 Sale$3.862,0007,720744,000Apr 09, 2021, 05:25 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANDec 01, 2020 Option Exercise$2.341,2502,9259,376,700Apr 09, 2021, 05:24 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANJun 01, 2020 Option Exercise$1.691,6022,7079,375,450Apr 09, 2021, 05:24 PM
Hunter RobynChief Financial OfficerSep 22, 2020 Sale$4.3828,450124,611192,169Sep 25, 2020, 06:37 PM
Hoenlein MalcolmDirectorAug 26, 2020 Buy$18.0016,667300,00616,667Sep 01, 2020, 08:34 AM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANAug 26, 2020 Buy$18.0052,500945,00092,500Sep 01, 2020, 08:32 AM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANJun 03, 2019 Buy$1.101,4671,6148,571,189Mar 13, 2020, 04:08 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANDec 01, 2019 Buy$2.061,1232,3138,572,312Mar 13, 2020, 04:08 PM
Hunter RobynChief Financial OfficerJun 03, 2019 Buy$1.102,2972,527220,619Dec 31, 2019, 04:02 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMANJul 18, 2019 Option Exercise$1.26396,825499,9998,569,722Jul 19, 2019, 07:00 AM
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONSDec 11, 2018 Sale$1.0597,325102,191255,170Dec 13, 2018, 06:10 PM
Hunter RobynChief Financial OfficerNov 23, 2018 Sale$1.2920,37026,277239,759Nov 30, 2018, 05:26 PM
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONSDec 14, 2017 Sale$3.5512,00042,600352,495Dec 18, 2017, 06:46 PM
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONSDec 13, 2017 Sale$3.5719,00067,830364,495Dec 14, 2017, 08:18 PM
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONSDec 12, 2017 Sale$3.5925,59391,879383,495Dec 14, 2017, 08:18 PM
ROSENWALD LINDSAY A MDPRESIDENT, CEONov 06, 2017 Buy$25.0040,0001,000,00040,000Nov 08, 2017, 06:02 PM
ROSENWALD LINDSAY A MDPresident and CEODec 01, 2016 Buy$2.037311,4845,304,470Jan 27, 2017, 04:12 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 16, 2016 Sale$2.5533,91286,476259,088Sep 19, 2016, 04:23 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 15, 2016 Sale$2.5415,00038,100293,000Sep 19, 2016, 04:23 PM
ROSENWALD LINDSAY A MDPresident and CEOJun 01, 2016 Buy$2.406131,4715,303,739Jun 17, 2016, 04:01 PM
ROSENWALD LINDSAY A MDPresident and CEODec 01, 2015 Buy$2.415861,4124,792,692Dec 09, 2015, 04:54 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 11, 2015 Option Exercise$2.6831,29983,900158,000Sep 14, 2015, 05:10 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 10, 2015 Option Exercise$2.6222,73759,555189,299Sep 14, 2015, 05:10 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 08, 2015 Option Exercise$2.5711,70430,102226,136Sep 10, 2015, 05:19 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 09, 2015 Option Exercise$2.6214,10036,941212,036Sep 10, 2015, 05:19 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 04, 2015 Option Exercise$2.602,1365,554237,840Sep 08, 2015, 05:10 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 03, 2015 Option Exercise$2.5818,20047,029239,976Sep 04, 2015, 05:20 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 02, 2015 Option Exercise$2.6024,90064,690258,176Sep 04, 2015, 05:20 PM
Avgerinos GeorgeSVP, Biologics OperationsSep 01, 2015 Option Exercise$2.70158427283,076Sep 03, 2015, 05:47 PM
Avgerinos GeorgeSVP, Biologics OperationsAug 31, 2015 Option Exercise$2.943,50010,295283,234Sep 02, 2015, 05:10 PM
Avgerinos GeorgeSVP, Biologics OperationsAug 21, 2015 Option Exercise$2.5510,00025,458286,734Aug 25, 2015, 04:26 PM
Avgerinos GeorgeSVP, Biologics OperationsAug 19, 2015 Option Exercise$3.0011,26633,798296,734Aug 21, 2015, 01:57 PM
ROSENWALD LINDSAY A MDPresident and CEOJun 01, 2015 Buy$1.807851,4134,792,106Jun 03, 2015, 04:33 PM
ROSENWALD LINDSAY A MDPresident and CEODec 01, 2014 Buy$1.459741,4124,791,321Dec 03, 2014, 04:51 PM
Lu LucyChief Financial OfficerDec 01, 2014 Buy$1.455,0007,25035,631Dec 03, 2014, 04:50 PM
WEISS MICHAEL SExec. VC - Strategic Dev.Nov 06, 2014 Buy$1.611,000,0001,610,0006,938,038Nov 10, 2014, 04:25 PM
Hoenlein MalcolmDirectorNov 06, 2014 Buy$1.6125,00040,25055,000Nov 10, 2014, 04:23 PM
ROSENWALD LINDSAY A MDPresident and CEONov 06, 2014 Buy$1.61150,000241,5004,790,347Nov 10, 2014, 04:19 PM
Lu LucyChief Financial OfficerJun 02, 2014 Buy$1.375,0006,85030,631Jun 04, 2014, 04:55 PM
HORGAN KEVINFormer Chief Medical OfficerApr 22, 2014 Option Exercise$1.7147,56681,33847,566Apr 23, 2014, 04:45 PM
HORGAN KEVINFormer Chief Medical OfficerApr 22, 2014 Sale$1.8947,56689,9760Apr 23, 2014, 04:45 PM
HORGAN KEVINFormer Chief Medical OfficerApr 21, 2014 Option Exercise$1.7119,00032,49019,000Apr 22, 2014, 04:32 PM
HORGAN KEVINFormer Chief Medical OfficerApr 21, 2014 Sale$1.8119,00034,3820Apr 22, 2014, 04:32 PM
HORGAN KEVINFormer Chief Medical OfficerApr 17, 2014 Option Exercise$1.71101173101Apr 21, 2014, 08:38 PM
HORGAN KEVINFormer Chief Medical OfficerApr 17, 2014 Sale$1.851011870Apr 21, 2014, 08:38 PM
ROSENWALD LINDSAY A MDPresident and CEOJan 23, 2012 Buy$6.952,00013,9002,461,001Mar 26, 2014, 04:14 PM
Lu LucyChief Financial OfficerJul 17, 2013 Buy$7.904,54535,90619,524Jan 10, 2014, 04:14 PM
Lu LucyChief Financial OfficerDec 04, 2013 Buy$1.391,1071,53925,631Jan 07, 2014, 05:02 PM
Lu LucyChief Financial OfficerAug 21, 2013 Buy$7.385,00036,90024,524Aug 22, 2013, 04:18 PM
LOBELL J JAYDirectorAug 21, 2013 Buy$7.375,00036,850336,000Aug 22, 2013, 04:17 PM
Lu LucyChief Financial OfficerJul 17, 2013 Buy$7.904,54535,90619,524Jul 18, 2013, 08:32 PM
Weisman Harlan FChairman and CEOJun 20, 2013 Buy$7.5910,00075,90030,000Jun 21, 2013, 05:59 PM
LOBELL J JAYDirectorJun 20, 2013 Buy$7.6210,00076,231331,000Jun 21, 2013, 05:57 PM
RITTER DALESVP & Chief Accounting OfficerMay 31, 2013 Buy$3.881,5035,83211,503Jun 04, 2013, 05:02 PM
Lu LucyChief Financial OfficerMay 31, 2013 Buy$3.884,97919,31914,979Jun 04, 2013, 05:01 PM
Beerman Noah DExecutive VP and COOMay 31, 2013 Buy$3.885,00019,40015,000Jun 04, 2013, 04:58 PM
Weisman Harlan FChairman and CEOJan 14, 2013 Buy$5.7120,000114,20020,000Jan 15, 2013, 06:11 PM
SANDAGE BOBBY W PHDPresident and CEONov 30, 2012 Buy$4.023,81115,32025,311Dec 03, 2012, 05:17 PM
COOPER GLENN L MDSee RemarksNov 30, 2012 Buy$4.023,81115,32043,811Dec 03, 2012, 05:14 PM
ROSENWALD LINDSAY A MDDirectorJun 22, 2012 Buy$5.00200,0001,000,0002,659,001Jun 26, 2012, 04:19 PM
Lu LucyChief Financial OfficerJun 22, 2012 Buy$5.0010,00050,00010,000Jun 26, 2012, 04:16 PM
Hehenberger Karin M.See RemarksJun 22, 2012 Buy$5.0020,000100,00020,925Jun 26, 2012, 04:15 PM
SANDAGE BOBBY W PHDPresident and CEOJun 22, 2012 Buy$5.0010,00050,00021,500Jun 26, 2012, 04:12 PM
Beerman Noah DEVP & COOJun 22, 2012 Buy$5.005,00025,00010,000Jun 26, 2012, 04:11 PM
LOBELL J JAYDirectorJun 22, 2012 Buy$5.0025,000125,000321,000Jun 26, 2012, 04:11 PM
COOPER GLENN L MDSee RemarksJun 22, 2012 Buy$5.3010,00052,96840,000Jun 26, 2012, 04:09 PM
RITTER DALESVP & Chief Accounting OfficerJun 22, 2012 Buy$5.005,00025,00010,000Jun 26, 2012, 04:07 PM
ROSENWALD LINDSAY A MDDirectorJan 23, 2012 Buy$6.952,00013,9002,459,001Feb 14, 2012, 04:28 PM
ROSENWALD LINDSAY A MDDirectorJan 23, 2012 Buy$6.952,00013,9002,425,632Jan 23, 2012, 07:42 PM
ROSENWALD LINDSAY A MDDirectorJan 20, 2012 Buy$5.662,00011,3202,423,632Jan 20, 2012, 06:30 PM
ROSENWALD LINDSAY A MDDirectorJan 19, 2012 Buy$5.672,00011,3402,421,632Jan 19, 2012, 05:13 PM
ROSENWALD LINDSAY A MDDirectorJan 18, 2012 Buy$5.662,00011,3202,419,632Jan 18, 2012, 06:41 PM
ROSENWALD LINDSAY A MDDirectorJan 17, 2012 Buy$5.402,00010,8002,417,632Jan 17, 2012, 08:31 PM
ROSENWALD LINDSAY A MDDirectorJan 13, 2012 Buy$5.402,00010,8002,415,632Jan 13, 2012, 09:16 PM
Beerman Noah DSee RemarksJan 12, 2012 Buy$4.995,00024,9605,000Jan 12, 2012, 04:52 PM
SANDAGE BOBBY W PHDPresident and CEOJan 11, 2012 Buy$5.285002,642500Jan 12, 2012, 04:49 PM
SANDAGE BOBBY W PHDPresident and CEOJan 12, 2012 Buy$5.201,0005,1951,500Jan 12, 2012, 04:49 PM
ROSENWALD LINDSAY A MDDirectorJan 11, 2012 Buy$5.492,00010,9802,411,632Jan 12, 2012, 04:46 PM
ROSENWALD LINDSAY A MDDirectorJan 12, 2012 Buy$5.202,00010,4002,413,632Jan 12, 2012, 04:46 PM
ROSENWALD LINDSAY A MDDirectorDec 08, 2011 Buy$7.002,00014,0002,409,632Dec 09, 2011, 06:20 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
ROSENWALD LINDSAY A MDPresident, CEO & Chairman01/05/2024118,770
ROSENWALD LINDSAY A MDPresident, CEO & Chairman11/14/20232,664,776
WEISS MICHAEL SSee Remarks11/14/2023249,999
ROSENWALD LINDSAY A MDPresident, CEO & Chairman09/26/202328,330
ROSENWALD LINDSAY A MDPresident, CEO & Chairman08/18/202393,400
ROSENWALD LINDSAY A MDPresident, CEO & Chairman08/17/2023117,500
WEISS MICHAEL SSee Remarks02/10/2023999,999
Rowinsky Eric KDirector02/10/202310,000
ROSENWALD LINDSAY A MDPresident, CEO & Chairman02/10/20231,999,999
Jin DavidChief Financial Officer02/10/202330,000
ROSENWALD LINDSAY A MDPresident, CEO & Chairman06/01/20223,113
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN12/01/202267,960
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN11/30/20222,800
Jin DavidChief Financial Officer11/30/20222,800
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN10/21/202269,500
Klein DovDirector12/28/202112,250
Hunter RobynChief Financial Officer09/21/202188,554
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN12/01/20213,025
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN06/01/20212,996
Rowinsky Eric KDirector02/05/202115,200
Rowinsky Eric KDirector03/02/202144,500
Rowinsky Eric KDirector02/19/202134,480
Rowinsky Eric KDirector02/18/202125,200
Rowinsky Eric KDirector02/16/20217,720
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN12/01/20202,925
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN06/01/20202,707
Hunter RobynChief Financial Officer09/22/2020124,611
Hoenlein MalcolmDirector08/26/2020300,006
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN08/26/2020945,000
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN06/03/20191,614
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN12/01/20192,313
Hunter RobynChief Financial Officer06/03/20192,527
ROSENWALD LINDSAY A MDPRESIDENT, CEO & CHAIRMAN07/18/2019499,999
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONS12/11/2018102,191
Hunter RobynChief Financial Officer11/23/201826,277
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONS12/14/201742,600
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONS12/13/201767,830
Avgerinos GeorgeSVP, BIOLOGICS OPERATIONS12/12/201791,879
ROSENWALD LINDSAY A MDPRESIDENT, CEO11/06/20171,000,000
ROSENWALD LINDSAY A MDPresident and CEO12/01/20161,484
Avgerinos GeorgeSVP, Biologics Operations09/16/201686,476
Avgerinos GeorgeSVP, Biologics Operations09/15/201638,100
ROSENWALD LINDSAY A MDPresident and CEO06/01/20161,471
ROSENWALD LINDSAY A MDPresident and CEO12/01/20151,412
Avgerinos GeorgeSVP, Biologics Operations09/11/201583,900
Avgerinos GeorgeSVP, Biologics Operations09/10/201559,555
Avgerinos GeorgeSVP, Biologics Operations09/08/201530,102
Avgerinos GeorgeSVP, Biologics Operations09/09/201536,941
Avgerinos GeorgeSVP, Biologics Operations09/04/20155,554
Avgerinos GeorgeSVP, Biologics Operations09/03/201547,029
Avgerinos GeorgeSVP, Biologics Operations09/02/201564,690
Avgerinos GeorgeSVP, Biologics Operations09/01/2015427
Avgerinos GeorgeSVP, Biologics Operations08/31/201510,295
Avgerinos GeorgeSVP, Biologics Operations08/21/201525,458
Avgerinos GeorgeSVP, Biologics Operations08/19/201533,798
ROSENWALD LINDSAY A MDPresident and CEO06/01/20151,413
ROSENWALD LINDSAY A MDPresident and CEO12/01/20141,412
Lu LucyChief Financial Officer12/01/20147,250
WEISS MICHAEL SExec. VC - Strategic Dev.11/06/20141,610,000
Hoenlein MalcolmDirector11/06/201440,250
ROSENWALD LINDSAY A MDPresident and CEO11/06/2014241,500
Lu LucyChief Financial Officer06/02/20146,850
HORGAN KEVINFormer Chief Medical Officer04/22/201481,338
HORGAN KEVINFormer Chief Medical Officer04/22/201489,976
HORGAN KEVINFormer Chief Medical Officer04/21/201432,490
HORGAN KEVINFormer Chief Medical Officer04/21/201434,382
HORGAN KEVINFormer Chief Medical Officer04/17/2014173
HORGAN KEVINFormer Chief Medical Officer04/17/2014187
ROSENWALD LINDSAY A MDPresident and CEO01/23/201213,900
Lu LucyChief Financial Officer07/17/201335,906
Lu LucyChief Financial Officer12/04/20131,539
Lu LucyChief Financial Officer08/21/201336,900
LOBELL J JAYDirector08/21/201336,850
Lu LucyChief Financial Officer07/17/201335,906
Weisman Harlan FChairman and CEO06/20/201375,900
LOBELL J JAYDirector06/20/201376,231
RITTER DALESVP & Chief Accounting Officer05/31/20135,832
Lu LucyChief Financial Officer05/31/201319,319
Beerman Noah DExecutive VP and COO05/31/201319,400
Weisman Harlan FChairman and CEO01/14/2013114,200
SANDAGE BOBBY W PHDPresident and CEO11/30/201215,320
COOPER GLENN L MDSee Remarks11/30/201215,320
ROSENWALD LINDSAY A MDDirector06/22/20121,000,000
Lu LucyChief Financial Officer06/22/201250,000
Hehenberger Karin M.See Remarks06/22/2012100,000
SANDAGE BOBBY W PHDPresident and CEO06/22/201250,000
Beerman Noah DEVP & COO06/22/201225,000
LOBELL J JAYDirector06/22/2012125,000
COOPER GLENN L MDSee Remarks06/22/201252,968
RITTER DALESVP & Chief Accounting Officer06/22/201225,000
ROSENWALD LINDSAY A MDDirector01/23/201213,900
ROSENWALD LINDSAY A MDDirector01/23/201213,900
ROSENWALD LINDSAY A MDDirector01/20/201211,320
ROSENWALD LINDSAY A MDDirector01/19/201211,340
ROSENWALD LINDSAY A MDDirector01/18/201211,320
ROSENWALD LINDSAY A MDDirector01/17/201210,800
ROSENWALD LINDSAY A MDDirector01/13/201210,800
Beerman Noah DSee Remarks01/12/201224,960
SANDAGE BOBBY W PHDPresident and CEO01/11/20122,642
SANDAGE BOBBY W PHDPresident and CEO01/12/20125,195
ROSENWALD LINDSAY A MDDirector01/11/201210,980
ROSENWALD LINDSAY A MDDirector01/12/201210,400
ROSENWALD LINDSAY A MDDirector12/08/201114,000
Load More Insider Transactions
FUNDS WITH A POSITION IN FORTRESS BIOTECH INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.1,124,1120.00001%ExitedOther
GEODE CAPITAL MANAGEMENT, LLC900,4000.00003%ExitedOther
RENAISSANCE TECHNOLOGIES LLC323,6270.00016%ExitedOther
BLACKROCK INC.74,9390.00001%NewOther
GEODE CAPITAL MANAGEMENT, LLC56,6990.00002%NewOther
RENAISSANCE TECHNOLOGIES LLC25,8670.00012%NewOther
CHANGE IN SHARES OUTSTANDING FOR FORTRESS BIOTECH INC
STOCK BUYBACKS FOR FORTRESS BIOTECH INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
1.64%
1Q
09/30/2023
03/31/2023
10.40%
2Q
09/30/2023
12/31/2022
24.12%
3Q
09/30/2023
09/30/2022
25.78%
4Q
09/30/2023
06/30/2022
26.75%
5Q
09/30/2023
03/31/2022
30.40%
6Q
09/30/2023
12/31/2021
34.49%
7Q
09/30/2023
09/30/2021
38.27%
8Q
09/30/2023
06/30/2021
38.93%
9Q
09/30/2023
03/31/2021
39.12%
10Q
09/30/2023
12/31/2020
40.94%
11Q
09/30/2023
09/30/2020
47.82%
12Q
09/30/2023
06/30/2020
64.08%
13Q
09/30/2023
03/31/2020
77.14%
14Q
09/30/2023
12/31/2019
88.52%
15Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
1.64%
1Q
03/31/2023
10.40%
2Q
12/31/2022
24.12%
3Q
09/30/2022
25.78%
4Q
06/30/2022
26.75%
5Q
03/31/2022
30.40%
6Q
12/31/2021
34.49%
7Q
09/30/2021
38.27%
8Q
06/30/2021
38.93%
9Q
03/31/2021
39.12%
10Q
12/31/2020
40.94%
11Q
09/30/2020
47.82%
12Q
06/30/2020
64.08%
13Q
03/31/2020
77.14%
14Q
12/31/2019
88.52%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR FORTRESS BIOTECH INC
LOADING...